JP2007197470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007197470A5 JP2007197470A5 JP2007127589A JP2007127589A JP2007197470A5 JP 2007197470 A5 JP2007197470 A5 JP 2007197470A5 JP 2007127589 A JP2007127589 A JP 2007127589A JP 2007127589 A JP2007127589 A JP 2007127589A JP 2007197470 A5 JP2007197470 A5 JP 2007197470A5
- Authority
- JP
- Japan
- Prior art keywords
- ehv
- vaccine
- inactivated
- virus
- equine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 16
- 241000701081 Equid alphaherpesvirus 1 Species 0.000 claims 14
- 241000700605 Viruses Species 0.000 claims 10
- 241000283086 Equidae Species 0.000 claims 9
- 241000230501 Equine herpesvirus sp. Species 0.000 claims 7
- 241000283073 Equus caballus Species 0.000 claims 7
- 241000701089 Equid alphaherpesvirus 4 Species 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 239000002671 adjuvant Substances 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 230000003053 immunization Effects 0.000 claims 5
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 4
- 150000001735 carboxylic acids Chemical class 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 229920000642 polymer Polymers 0.000 claims 4
- 241000712461 unidentified influenza virus Species 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 241000282693 Cercopithecidae Species 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229940124841 Herpesvirus vaccine Drugs 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000000227 bioadhesive Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/812,720 US6803041B2 (en) | 2001-03-20 | 2001-03-20 | Equine herpesvirus vaccine |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002573042A Division JP4177112B2 (ja) | 2001-03-20 | 2002-01-23 | ウマヘルペスウイルスワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007197470A JP2007197470A (ja) | 2007-08-09 |
| JP2007197470A5 true JP2007197470A5 (enExample) | 2008-02-21 |
| JP4668951B2 JP4668951B2 (ja) | 2011-04-13 |
Family
ID=25210428
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002573042A Expired - Lifetime JP4177112B2 (ja) | 2001-03-20 | 2002-01-23 | ウマヘルペスウイルスワクチン |
| JP2007127589A Expired - Lifetime JP4668951B2 (ja) | 2001-03-20 | 2007-05-14 | ウマヘルペスウイルスワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002573042A Expired - Lifetime JP4177112B2 (ja) | 2001-03-20 | 2002-01-23 | ウマヘルペスウイルスワクチン |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US6803041B2 (enExample) |
| EP (2) | EP1372712B1 (enExample) |
| JP (2) | JP4177112B2 (enExample) |
| KR (1) | KR100840525B1 (enExample) |
| AR (2) | AR032984A1 (enExample) |
| AT (1) | ATE392903T1 (enExample) |
| CA (1) | CA2441292C (enExample) |
| CY (1) | CY1108200T1 (enExample) |
| DE (1) | DE60226218T2 (enExample) |
| DK (2) | DK1372712T3 (enExample) |
| ES (2) | ES2305220T3 (enExample) |
| MX (1) | MXPA03008287A (enExample) |
| NZ (1) | NZ529012A (enExample) |
| PT (1) | PT1372712E (enExample) |
| WO (1) | WO2002074335A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6803041B2 (en) * | 2001-03-20 | 2004-10-12 | Boehringer Ingelheim Vetmedica, Inc. | Equine herpesvirus vaccine |
| JP2005075752A (ja) * | 2003-08-29 | 2005-03-24 | Nippon Inst For Biological Science | 豚繁殖・呼吸障害症候群用ワクチン製剤 |
| US7572620B2 (en) | 2005-01-11 | 2009-08-11 | Wisconsin Alumni Research Foundation | H3 equine influenza A virus |
| BRPI0618041A2 (pt) * | 2005-11-01 | 2011-08-16 | Intervet Int Bv | uso de um vìrus inativado da influenza eqüina, e, método para a proteção de eqüinos contra a infecção com influenza eqüina |
| US9642908B2 (en) | 2008-07-30 | 2017-05-09 | University Of Kentucky Research Foundation | Equine disease model for herpesvirus neurologic disease and uses thereof |
| ES2675771T3 (es) | 2008-12-16 | 2018-07-12 | Ology Bioservices, Inc. | Producción de vacunas contra el virus de la gripe |
| WO2010144797A2 (en) | 2009-06-12 | 2010-12-16 | Vaccine Technologies, Incorporated | Influenza vaccines with enhanced immunogenicity and uses thereof |
| EP2569007B1 (en) * | 2010-05-11 | 2015-10-14 | Intervet International B.V. | Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies |
| ES2742325T3 (es) * | 2013-05-14 | 2020-02-13 | Zoetis Services Llc | Composiciones de vacuna novedosas que comprenden oligonucleótidos inmunoestimulantes |
| JP6560056B2 (ja) * | 2015-08-07 | 2019-08-14 | ウィスコンシン アルムニ リサーチ ファンデイション | Ｈ３型ウマａ型インフルエンザウイルス |
| US12258540B2 (en) | 2017-10-30 | 2025-03-25 | Takeda Pharmaceutical Company Limited | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| JP2018088928A (ja) * | 2018-02-13 | 2018-06-14 | ウィスコンシン アルムニ リサーチ ファンデイション | Ｈ３型ウマａ型インフルエンザウイルス |
| CA3225885A1 (en) * | 2021-08-06 | 2023-02-09 | Sylvia REEMERS | Vaccine for equine herpesvirus |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3920811A (en) * | 1972-12-22 | 1975-11-18 | Cutter Lab | Adjuvant compositions |
| US4110433A (en) | 1976-04-23 | 1978-08-29 | Philips Roxane, Inc. | Equine rhinopneumonitis virus |
| US4083958A (en) | 1976-09-13 | 1978-04-11 | The University Of Kentucky Research Foundation | Inactivated equine rhinopneumonitis virus vaccine and use thereof |
| US4225582A (en) | 1979-03-08 | 1980-09-30 | The University Of Illinois Foundation | Vaccine for equine rhinopneumonitis |
| US4500513A (en) * | 1979-05-15 | 1985-02-19 | Miles Laboratories, Inc. | Influenza vaccine production in liquid cell culture |
| US4509949A (en) | 1983-06-13 | 1985-04-09 | The B. F. Goodrich Company | Water thickening agents consisting of copolymers of crosslinked acrylic acids and esters |
| EP0501523B1 (en) | 1983-11-14 | 1997-04-09 | Columbia Laboratories, Inc. | Bioadhesive compositions |
| US5084271B1 (en) | 1984-09-11 | 1997-08-05 | Univ Melbourne | Vaccine for equine herpesvirus |
| US4758641A (en) | 1987-02-24 | 1988-07-19 | The B F Goodrich Company | Polycarboxylic acids with small amount of residual monomer |
| NZ224422A (en) | 1987-05-05 | 1990-11-27 | Molecular Eng Ass | Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid |
| US5221722A (en) | 1988-11-28 | 1993-06-22 | The B. F. Goodrich Company | Crosslinked polyacrylic acid |
| US5292653A (en) * | 1989-09-27 | 1994-03-08 | Novagene, Inc. | Equine herpesvirus 1 tk mutants |
| GB9014950D0 (en) * | 1990-07-06 | 1990-08-29 | Univ Glasgow | Ehv-4 glycoprotein vaccine |
| US6025181A (en) * | 1990-07-06 | 2000-02-15 | University Court Of The University Of Glasgow | Equine herpesvirus-4TK mutant |
| DE69131984T2 (de) | 1990-08-01 | 2000-07-06 | Research Corp. Technologies, Inc. | Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung |
| US5462734A (en) * | 1990-11-02 | 1995-10-31 | Wisconsin Alumni Research Foundation | Bovine herpesvirus vaccine and method of using same |
| EP0532833A1 (en) | 1991-05-28 | 1993-03-24 | Miles Inc. | Vaccine for equine rhinopneumonitis |
| DE69333416D1 (de) | 1992-06-01 | 2004-03-18 | Univ Melbourne Parkville | Immunologisches Verfahren für die Detektion von Pferde-Herpesvirus Typ 1 und 4 glycoprotein G Antikörper |
| US6193983B1 (en) * | 1992-06-01 | 2001-02-27 | The University Of Melbourne | Equine herpesvirus glycoproteins |
| US6225111B1 (en) * | 1992-08-07 | 2001-05-01 | Schering Plough Veterinary Corp. | Recombinant equine herpesviruses |
| AUPN720195A0 (en) | 1995-12-18 | 1996-01-18 | University Of Melbourne, The | Equine rhinovirus 1 proteins |
| FR2751226B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
| US5853715A (en) * | 1996-08-16 | 1998-12-29 | Bayer Corporation | Cross-protective equine herpesvirus preparations and method of making and using the same |
| JP2002504227A (ja) | 1997-03-12 | 2002-02-05 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | クロマトグラフィーカラムの末端部材 |
| US5891705A (en) * | 1997-04-08 | 1999-04-06 | Pentose Pharmaceuticals, Inc. | Method for inactivating a virus |
| EP0978286A1 (en) | 1998-08-07 | 2000-02-09 | Bayer Corporation | Cross-protective equine herpesvirus preparations and method of making and using the same |
| US6803041B2 (en) * | 2001-03-20 | 2004-10-12 | Boehringer Ingelheim Vetmedica, Inc. | Equine herpesvirus vaccine |
-
2001
- 2001-03-20 US US09/812,720 patent/US6803041B2/en not_active Expired - Lifetime
-
2002
- 2002-01-23 DK DK02713437T patent/DK1372712T3/da active
- 2002-01-23 EP EP02713437A patent/EP1372712B1/en not_active Expired - Lifetime
- 2002-01-23 NZ NZ529012A patent/NZ529012A/en not_active IP Right Cessation
- 2002-01-23 DK DK08150506.7T patent/DK1923071T3/da active
- 2002-01-23 PT PT02713437T patent/PT1372712E/pt unknown
- 2002-01-23 ES ES02713437T patent/ES2305220T3/es not_active Expired - Lifetime
- 2002-01-23 WO PCT/US2002/001644 patent/WO2002074335A2/en not_active Ceased
- 2002-01-23 ES ES08150506T patent/ES2428664T3/es not_active Expired - Lifetime
- 2002-01-23 KR KR1020037012273A patent/KR100840525B1/ko not_active Expired - Lifetime
- 2002-01-23 DE DE60226218T patent/DE60226218T2/de not_active Expired - Lifetime
- 2002-01-23 CA CA2441292A patent/CA2441292C/en not_active Expired - Lifetime
- 2002-01-23 AT AT02713437T patent/ATE392903T1/de active
- 2002-01-23 MX MXPA03008287A patent/MXPA03008287A/es active IP Right Grant
- 2002-01-23 EP EP08150506.7A patent/EP1923071B1/en not_active Expired - Lifetime
- 2002-01-23 JP JP2002573042A patent/JP4177112B2/ja not_active Expired - Lifetime
- 2002-03-13 AR ARP020100906A patent/AR032984A1/es unknown
-
2004
- 2004-07-23 US US10/897,984 patent/US7226604B2/en not_active Expired - Lifetime
-
2007
- 2007-04-26 US US11/789,919 patent/US20070196390A1/en not_active Abandoned
- 2007-05-14 JP JP2007127589A patent/JP4668951B2/ja not_active Expired - Lifetime
-
2008
- 2008-07-17 CY CY20081100745T patent/CY1108200T1/el unknown
-
2013
- 2013-05-31 AR ARP130101929 patent/AR091235A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007197470A5 (enExample) | ||
| Dugan et al. | Aging and influenza vaccine-induced immunity | |
| EP2452693A3 (en) | Vaccines and methods to treat canine influenza | |
| JP2011511754A5 (enExample) | ||
| JP5762307B2 (ja) | 経鼻投与用ワクチンを用いるインフルエンザの予防方法 | |
| JP2009539965A5 (enExample) | ||
| EP4368202A3 (en) | Attenuated viruses useful for vaccines | |
| RU2016115052A (ru) | Комплекс, содержащий олигонуклеотид, обладающий иммуностимулирующей активностью, и его применение | |
| MA33449B1 (fr) | Antigènes recombinants du vrs | |
| JP2011250797A5 (enExample) | ||
| JP2008535496A5 (enExample) | ||
| JP2011504486A5 (enExample) | ||
| JP2016525102A5 (enExample) | ||
| EP1854886A3 (en) | Cold-adapted equine influenza viruses | |
| AR091235A2 (es) | Vacuna contra herpesvirus equinos | |
| RU2017137357A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| JP2017524682A5 (enExample) | ||
| WO2001060849A3 (en) | Cold-adapted equine influenza viruses | |
| JP2013503880A5 (enExample) | ||
| JP2006512413A5 (enExample) | ||
| WO2001074386A3 (en) | Cold-adapted equine influenza viruses | |
| JP2007530703A5 (enExample) | ||
| WO2010028072A3 (en) | Avian antibodies specific to influenza virus and technologically simple methods of their manufacture and use | |
| AR065765A1 (es) | Composicion de vacuna para el tratamiento de enfermedades infecciosas respiratorias | |
| JP2016520077A5 (enExample) |